| Date | Time | Source | Headline | Symbol | Company |
| 04/15/2019 | 4:32PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:VTL | Vital Therapies, Inc. (MM) |
| 04/12/2019 | 1:01PM | PR Newswire (US) | Immunic Therapeutics and Vital Therapies Complete Transaction Creating Nasdaq-Listed Company Targeting Chronic Inflammatory a... | NASDAQ:VTL | Vital Therapies, Inc. (MM) |
| 04/10/2019 | 4:45PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:VTL | Vital Therapies, Inc. (MM) |
| 04/10/2019 | 4:35PM | GlobeNewswire Inc. | Vital Therapies, Inc. Announces Filing of its Form 10-Q for the Quarter Ended March 31, 2019 | NASDAQ:VTL | Vital Therapies, Inc. (MM) |
| 04/10/2019 | 4:19PM | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:VTL | Vital Therapies, Inc. (MM) |
| 04/04/2019 | 4:07PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:VTL | Vital Therapies, Inc. (MM) |
| 04/04/2019 | 4:07PM | GlobeNewswire Inc. | Vital Therapies, Inc. Announces Stockholder Approval of Business Combination with Immunic AG | NASDAQ:VTL | Vital Therapies, Inc. (MM) |
| 04/02/2019 | 4:20PM | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:VTL | Vital Therapies, Inc. (MM) |
| 03/27/2019 | 4:08PM | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (defa14a) | NASDAQ:VTL | Vital Therapies, Inc. (MM) |
| 03/27/2019 | 6:00AM | GlobeNewswire Inc. | Vital Therapies Reminds Stockholders to Vote For the Proposed Business Combination With Immunic AG | NASDAQ:VTL | Vital Therapies, Inc. (MM) |
| 03/25/2019 | 4:07PM | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (defa14a) | NASDAQ:VTL | Vital Therapies, Inc. (MM) |
| 03/25/2019 | 5:00AM | GlobeNewswire Inc. | Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Vital Therapies Stockholders Vote “FOR” the Prop... | NASDAQ:VTL | Vital Therapies, Inc. (MM) |
| 03/22/2019 | 4:09PM | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (defa14a) | NASDAQ:VTL | Vital Therapies, Inc. (MM) |
| 03/19/2019 | 5:20PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:VTL | Vital Therapies, Inc. (MM) |
| 03/14/2019 | 4:04PM | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:VTL | Vital Therapies, Inc. (MM) |
| 03/13/2019 | 4:01PM | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (defa14a) | NASDAQ:VTL | Vital Therapies, Inc. (MM) |
| 03/04/2019 | 5:17PM | Edgar (US Regulatory) | Annual Report (10-k) | NASDAQ:VTL | Vital Therapies, Inc. (MM) |
| 03/04/2019 | 4:23PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:VTL | Vital Therapies, Inc. (MM) |
| 03/04/2019 | 4:10PM | GlobeNewswire Inc. | Vital Therapies Announces 2018 Financial Results | NASDAQ:VTL | Vital Therapies, Inc. (MM) |
| 02/28/2019 | 4:21PM | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:VTL | Vital Therapies, Inc. (MM) |
| 02/26/2019 | 4:18PM | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:VTL | Vital Therapies, Inc. (MM) |
| 02/19/2019 | 5:05PM | Edgar (US Regulatory) | Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) | NASDAQ:VTL | Vital Therapies, Inc. (MM) |
| 02/15/2019 | 6:33AM | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:VTL | Vital Therapies, Inc. (MM) |
| 02/14/2019 | 9:04AM | Edgar (US Regulatory) | Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a) | NASDAQ:VTL | Vital Therapies, Inc. (MM) |
| 02/06/2019 | 4:37PM | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:VTL | Vital Therapies, Inc. (MM) |
| 02/04/2019 | 6:01PM | Edgar (US Regulatory) | Securities Registration: Business Combination (s-4) | NASDAQ:VTL | Vital Therapies, Inc. (MM) |
| 02/01/2019 | 3:39PM | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:VTL | Vital Therapies, Inc. (MM) |
| 01/24/2019 | 5:07PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:VTL | Vital Therapies, Inc. (MM) |
| 01/14/2019 | 4:53PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:VTL | Vital Therapies, Inc. (MM) |
| 01/07/2019 | 4:43PM | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:VTL | Vital Therapies, Inc. (MM) |